These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18481821)

  • 1. Antiplatelet therapy and platelet function testing.
    Braunwald E; Angiolillo D; Bates E; Berger PB; Bhatt D; Cannon CP; Furman MI; Gurbel P; Michelson AD; Peterson E; Wiviott S
    Clin Cardiol; 2008 Mar; 31(3 Suppl 1):I36. PubMed ID: 18481821
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet therapy and platelet function testing. Introduction.
    Braunwald E; Angiolillo D; Bates E; Berger PB; Bhatt D; Cannon CP; Furman MI; Gurbel P; Michelson AD; Peterson E; Wiviott S
    Clin Cardiol; 2008 Mar; 31(3 Suppl 1):I1. PubMed ID: 18481815
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiplatelet therapy: cangrelor for ACS-lessons from the CHAMPION trials.
    Faxon DP
    Nat Rev Cardiol; 2010 Mar; 7(3):124-5. PubMed ID: 20179718
    [No Abstract]   [Full Text] [Related]  

  • 4. Resisting the temptation to oversimplify antiplatelet resistance.
    Bhatt DL
    JACC Cardiovasc Interv; 2008 Dec; 1(6):660-2. PubMed ID: 19463381
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes.
    Braunwald E; Angiolillo D; Bates E; Berger PB; Bhatt D; Cannon CP; Furman MI; Gurbel P; Michelson AD; Peterson E; Wiviott S
    Clin Cardiol; 2008 Mar; 31(3 Suppl 1):I2-9. PubMed ID: 18481818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.
    Würtz M; Grove EL; Wulff LN; Kaltoft AK; Tilsted HH; Jensen LO; Hvas AM; Kristensen SD
    JACC Cardiovasc Interv; 2010 Aug; 3(8):828-35. PubMed ID: 20723855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated high doses of clopidogrel in 2 cases of pharmacological resistance.
    Cayla G; Macia JC; Roubille F; Rabesendratana H; Piot C; Schved JF; Leclercq F
    Circ J; 2008 Dec; 72(12):2098-100. PubMed ID: 18854615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel platelet ADP P2Y12 inhibitors in the treatment of acute coronary syndrome.
    Tan GM; Lam YY; Yan BP
    Cardiovasc Ther; 2012 Aug; 30(4):e167-73. PubMed ID: 21883998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving role of platelet function testing in coronary artery interventions.
    Sharma RK; Voelker DJ; Sharma R; Reddy HK; Dod H; Marsh JD
    Vasc Health Risk Manag; 2012; 8():65-75. PubMed ID: 22371653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel response: head-to-head comparison of different platelet assays to identify clopidogrel non responder patients after coronary stenting.
    Cuisset T; Frere C; Poyet R; Quilici J; Gaborit B; Bali L; Brissy O; Lambert M; Morange PE; Alessi MC; Bonnet JL
    Arch Cardiovasc Dis; 2010 Jan; 103(1):39-45. PubMed ID: 20142119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet resistance--fact or myth?
    Gurbel PA; Tantry US
    Am Heart Hosp J; 2009; 7(1):50-7. PubMed ID: 19742434
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronary artery disease: Platelet activity: an obstacle for successful PCI.
    Gawaz M; Geisler T
    Nat Rev Cardiol; 2009 Jun; 6(6):391-2. PubMed ID: 19471282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.
    Paniccia R; Antonucci E; Maggini N; Miranda M; Gori AM; Marcucci R; Giusti B; Balzi D; Prisco D; Abbate R
    Thromb Haemost; 2010 Aug; 104(2):287-92. PubMed ID: 20458439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting thrombotic events: creating a complex approach for a complex condition.
    Shantsila E; Lip GY
    Thromb Haemost; 2008 Dec; 100(6):962-4. PubMed ID: 19132217
    [No Abstract]   [Full Text] [Related]  

  • 15. New directions in antiplatelet therapy.
    Ferreiro JL; Angiolillo DJ
    Circ Cardiovasc Interv; 2012 Jun; 5(3):433-45. PubMed ID: 22715450
    [No Abstract]   [Full Text] [Related]  

  • 16. The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention.
    Braunwald E; Angiolillo D; Bates E; Berger PB; Bhatt D; Cannon CP; Furman MI; Gurbel P; Michelson AD; Peterson E; Wiviott S
    Clin Cardiol; 2008 Mar; 31(3 Suppl 1):I17-20. PubMed ID: 18481817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thienopyridines: time for personalized therapy?
    King SB; Momary KM
    JACC Cardiovasc Interv; 2008 Dec; 1(6):718-9. PubMed ID: 19463390
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet function testing in practice: a case study.
    Mahmud E; Ang L
    Rev Cardiovasc Med; 2011; 12 Suppl 1():S34-9. PubMed ID: 22080985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention.
    Kwan J; Htun WW; Huang Y; Ko W; Kwan TW
    Vasc Health Risk Manag; 2011; 7():399-404. PubMed ID: 21796254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Thromb Haemost; 2010 Aug; 104(2):279-86. PubMed ID: 20508896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.